Therapeutic benefit of decitabine, a hypomethylating agent,...

  • Main
  • 2015 / 6
  • Therapeutic benefit of decitabine, a hypomethylating agent,...

Therapeutic benefit of decitabine, a hypomethylating agent, in patients with high-risk primary myelofibrosis and myeloproliferative neoplasm in accelerated or blastic/acute myeloid leukemia phase

Badar, Talha, Kantarjian, Hagop M., Ravandi, Farhad, Jabbour, Elias, Borthakur, Gautam, Cortes, Jorge E., Pemmaraju, Naveen, Pierce, Sherry R., Newberry, Kate J., Daver, Naval, Verstovsek, Srdan
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Leukemia Research
DOI:
10.1016/j.leukres.2015.06.001
Date:
June, 2015
File:
PDF, 1.03 MB
english, 2015
Conversion to is in progress
Conversion to is failed